News & Updates

Antibody responses to COVID-19 vaccines in older people: Recent evidence & local data
Antibody responses to COVID-19 vaccines in older people: Recent evidence & local data
27 Jun 2022 byKanas Chan

Older adults have weaker antibody responses to two doses of COVID-19 vaccines [ie, mRNA-based BNT162b2 vaccine and inactivated CZ02 vaccine] vs younger individuals, but a booster dose mounts SARS-CoV-2 neutralization activities to a high level, according to data presented at AIM 2022.

Antibody responses to COVID-19 vaccines in older people: Recent evidence & local data
27 Jun 2022
Diabetes, fertility treatment, family history up autism risk in infants
Diabetes, fertility treatment, family history up autism risk in infants
26 Jun 2022
MACE, stroke, death common after acute coronary syndrome in people with bipolar disorder
MACE, stroke, death common after acute coronary syndrome in people with bipolar disorder
25 Jun 2022

In people with bipolar disorder, major adverse cardiovascular events (MACE) are common occurrences after acute coronary syndrome (ACS), a new study has found. Similarly, the risks of all-cause mortality and stroke are also increased post-ACS.

MACE, stroke, death common after acute coronary syndrome in people with bipolar disorder
25 Jun 2022
Tirzepatide: A winning weight-loss therapy for nondiabetic, obese adults
Tirzepatide: A winning weight-loss therapy for nondiabetic, obese adults
25 Jun 2022 byRoshini Claire Anthony

Non-diabetic overweight or obese adults experienced a greater reduction in weight and cardiometabolic measures with the addition of tirzepatide to their lifestyle interventions, findings of the SURMOUNT-1 trial showed.

Tirzepatide: A winning weight-loss therapy for nondiabetic, obese adults
25 Jun 2022